In the United States, UTIs are a severe public health problem that is becoming increasingly more difficult to manage
UTILITY therapeutics is committed to providing safe and effective therapies to combat UTIs
The growing threat of antimicrobial resistance, treatment overuse, and challenges with existing therapies further increase the economic and societal burden of these infections.1 UTILITY therapeutics is currently developing new antibiotic options to better help people suffering with UTIs in the United States.
WhoWe Are
UTILITY therapeutics is led by a team of industry leaders highly experienced in the launch and commercialization of anti-infectives in the United States and abroad
Urgent UnmetNeed in UTI
Existing first-line treatments for UTI pose significant therapeutic challenges, highlighting the need for innovative alternatives
Focusing onNovel MOA
Bringing new hope to patients with uncomplicated and complicated UTIs
Reference: 1. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269-284. doi:10.1038/nrmicro3432